Aldeyra Therapeutics, Inc. (ALDX): 4 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Jun 5, 2026 | Brady Todd C Director, Officer | 250,000 | $1.67 | $418.4K | no history |
| Mar 20, 2026 | Douglas Richard Director | 70,000 | $1.40 | $98.0K | no history |
| Mar 19, 2026 | Alfieri Michael Officer | 5,000 | $1.42 | $7.1K | no history |
| Aug 15, 2025 | Alfieri Michael Officer | 2,500 | $5.30 | $13.2K | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.